KUALA LUMPUR, Aug 3 — The Health Ministry (MOH) and the Domestic Trade and Cost of Living Ministry (KPDN) are implementing the drug price display initiative at private health facilities and community pharmacies in stages starting August 1.
The initiative, which was implemented under the Price Control and Anti-Profiteering (Price Marking of Medicines) Order 2025 [P.U.(A) 141/2025] under the Price Control and Anti-Profiteering Act 2011, began on May 1.
The educational enforcement approach was implemented in the first three months, ending on July 31.
"During the period, 842 facilities consisting of medical clinics, dental clinics and private hospitals as well as community pharmacies were inspected, and the majority of them have implemented this initiative, with 57 per cent of them complying with the requirements for satisfactory drug price display," both ministries said in a joint statement today.
In this regard, enforcement will continue in stages from August 1 through educational approach inspections and advocacy for two months until September 30, and a reminder letter may be issued in the event of non-compliance.
Starting October 1, compounds would be issued for repeat offences before full enforcement on January 1, 2026.
MOH and KPDN also took note of the judicial review action filed in the High Court by seven organisations representing medical and dental practitioners and one private medical practitioner regarding the validity of Order PU (A) 141/2025.
"However, until this statement is issued, there is no court order directing the suspension of the implementation or enforcement of this order. Therefore, Order P.U.(A) 141/2025 remains valid and in force," they said.
MOH and KPDN also expressed their commitment to implement the initiative in an inclusive, phased, and prudent manner to ensure that its benefits are enjoyed by consumers and contribute to increasing transparency, accountability, and trust in the country's health system.
